Press Releases

Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jul 17, 2019
Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients
Jul 11, 2019
Alector Announces Upcoming Presentations at 2019 Alzheimer's Association International Conference
May 08, 2019
Alector to Present at the Bank of America Merrill Lynch Healthcare Conference on May 15, 2019
May 06, 2019
Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002
Apr 17, 2019
Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001
Apr 01, 2019
Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimer’s Disease
Mar 26, 2019
Alector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial Results
Displaying 1 - 10 of 12
Top